Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Orenda ApS
APS
Dissolved
Advertising protection
CVR 40408169
Amager Strandvej 110B, 2300
København S
Manufacture of basic pharmaceutical products
·
NACE 2110
Est. 2019 · 7 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of basic pharmaceutical products
/
Orenda ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (4)
DA
Danielle Ann Grabowski
Management
Management
2019 – 2019
HG
Hardy Gunner Heard
Management
Management
2019 – 2019
SE
Steen Egsdal
Chief Executive Officer
Chief Executive Officer
2019 – 2020
CR
Connor Richard McCaffery
Chief Executive Officer
Chief Executive Officer
2020 – 2025
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Orenda Holding ApS — 100%
Danielle Ann Grabowski — 50–66.65%
Hardy Gunner Heard — 50–66.65%
100%
Shareholder
Type
Ownership
Votes
Since
Orenda Holding ApS
Company
100%
100%
2019
Danielle Ann Grabowski
Individual
50–66.65%
50–66.65%
2019
Hardy Gunner Heard
Individual
50–66.65%
50–66.65%
2019
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Orenda ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
